Company intelligence / Profile preview

i3 Pharmaceuticals

Warminster, Pennsylvania, United Statesi3pharmaceuticals.com ↗

Ownership: Private
Development stage: Commercial

Overview

i3 Pharmaceuticals develops, manufactures, and supplies complex solid oral generic pharmaceuticals, including sustained release formulations and products with enhanced bioavailability. The company specializes in technically challenging drugs such as poorly soluble or unstable molecules. Their pipeline includes several small molecule generic programs, with at least one program reaching the NDA/BLA stage.

Modalities: Small molecule
Industry: Biotech

Drug pipeline

6 assets

isosorbide dinitrate + hydralazine hydrochloride

Commercial

5 more assets in the full pipeline.

Request access →

Partnerships

Syneos Health (clinical trial sponsor/collaborator)

Beyond the preview

Go deeper on i3 Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on i3 Pharmaceuticals.

Explore the full profile